Skip to main content
PMC home page
The British Journal of General Practice logoLink to The British Journal of General Practice
. 1998 Nov;48(436):1775–1778.

A community survey of patients with atrial fibrillation: associated disabilities and treatment preferences.

M Sudlow 1, R Thomson 1, R A Kenny 1, H Rodgers 1
PMCID: PMC1313272  PMID: 10198488

Abstract

BACKGROUND: Anticoagulants are effective in preventing stroke in those with atrial fibrillation, but most patients remain untreated. AIM: To investigate the prevalence of disability, cognitive impairment, and problems with compliance in a representative sample of the elderly with atrial fibrillation, and to determine whether they would want treatment and how they would like services to be arranged. METHOD: In a survey of a random sample of 4843 elderly subjects, those with atrial fibrillation were identified using electrocardiograms. Views on treatment were obtained using a structured interview. Disability was assessed using the Office of Population Censuses and Surveys Disability Scale and cognitive status using the Mini Mental State Examination. General practitioners were asked, via questionnaire, for their views on each subject's compliance. RESULTS: Two hundred and seven elderly people with atrial fibrillation were identified. Almost all subjects expressed a willingness to undertake treatment to prevent stroke and preferred blood testing performed outside of hospital. Disability (82.7%), cognitive impairment (25.7%), and problems with compliance (25.0%) were common, but the prevalence of these difficulties was not substantially different from the general elderly population, and in many cases they could be overcome (e.g. only 10% of subjects had problems with compliance and no-one who could help them to comply). CONCLUSIONS: Most elderly people with atrial fibrillation would accept treatment to prevent stroke. Disability, cognitive impairment, and problems with compliance may make it difficult to treat this patient group. An increase in the use of anticoagulants should be accompanied by the development of services appropriate to this frail population.

Full Text

The Full Text of this article is available as a PDF (29.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bath P. M., Prasad A., Brown M. M., MacGregor G. A. Survey of use of anticoagulation in patients with atrial fibrillation. BMJ. 1993 Oct 23;307(6911):1045–1045. doi: 10.1136/bmj.307.6911.1045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Breteler M. M., Claus J. J., Grobbee D. E., Hofman A. Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. BMJ. 1994 Jun 18;308(6944):1604–1608. doi: 10.1136/bmj.308.6944.1604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Connolly S. J., Laupacis A., Gent M., Roberts R. S., Cairns J. A., Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol. 1991 Aug;18(2):349–355. doi: 10.1016/0735-1097(91)90585-w. [DOI] [PubMed] [Google Scholar]
  4. Ezekowitz M. D., Bridgers S. L., James K. E., Carliner N. H., Colling C. L., Gornick C. C., Krause-Steinrauf H., Kurtzke J. F., Nazarian S. M., Radford M. J. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med. 1992 Nov 12;327(20):1406–1412. doi: 10.1056/NEJM199211123272002. [DOI] [PubMed] [Google Scholar]
  5. Feinberg W. M., Blackshear J. L., Laupacis A., Kronmal R., Hart R. G. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med. 1995 Mar 13;155(5):469–473. [PubMed] [Google Scholar]
  6. Folstein M. F., Folstein S. E., McHugh P. R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–198. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
  7. Hendry A., Campbell A. M., Campbell G., Macdonald J. B., Williams B. O. Antithrombotic therapy prescribed for patients with non-rheumatic atrial fibrillation. Scott Med J. 1994 Aug;39(4):110–111. doi: 10.1177/003693309403900404. [DOI] [PubMed] [Google Scholar]
  8. Lawson F., McAlister F., Ackman M., Ikuta R., Montague T. The utilization of antithrombotic prophylaxis for atrial fibrillation in a geriatric rehabilitation hospital. J Am Geriatr Soc. 1996 Jun;44(6):708–711. doi: 10.1111/j.1532-5415.1996.tb01837.x. [DOI] [PubMed] [Google Scholar]
  9. Lip G. Y., Golding D. J., Nazir M., Beevers D. G., Child D. L., Fletcher R. I. A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project. Br J Gen Pract. 1997 May;47(418):285–289. [PMC free article] [PubMed] [Google Scholar]
  10. Lok N. S., Lau C. P. Presentation and management of patients admitted with atrial fibrillation: a review of 291 cases in a regional hospital. Int J Cardiol. 1995 Mar 3;48(3):271–278. doi: 10.1016/0167-5273(94)02259-l. [DOI] [PubMed] [Google Scholar]
  11. Man-Son-Hing M., Laupacis A., O'Connor A., Wells G., Lemelin J., Wood W., Dermer M. Warfarin for atrial fibrillation. The patient's perspective. Arch Intern Med. 1996 Sep 9;156(16):1841–1848. [PubMed] [Google Scholar]
  12. Petersen P., Boysen G., Godtfredsen J., Andersen E. D., Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet. 1989 Jan 28;1(8631):175–179. doi: 10.1016/s0140-6736(89)91200-2. [DOI] [PubMed] [Google Scholar]
  13. Sudlow C. M., Rodgers H., Kenny R. A., Thomson R. G. Service provision and use of anticoagulants in atrial fibrillation. BMJ. 1995 Aug 26;311(7004):558–560. doi: 10.1136/bmj.311.7004.558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Sudlow M., Rodgers H., Kenny R. A., Thomson R. Population based study of use of anticoagulants among patients with atrial fibrillation in the community. BMJ. 1997 May 24;314(7093):1529–1530. doi: 10.1136/bmj.314.7093.1529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sudlow M., Thomson R., Thwaites B., Rodgers H., Kenny R. A. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet. 1998 Oct 10;352(9135):1167–1171. doi: 10.1016/S0140-6736(98)01401-9. [DOI] [PubMed] [Google Scholar]
  16. Tombaugh T. N., McIntyre N. J. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992 Sep;40(9):922–935. doi: 10.1111/j.1532-5415.1992.tb01992.x. [DOI] [PubMed] [Google Scholar]
  17. Wheeldon N. M., Tayler D. I., Anagnostou E., Cook D., Wales C., Oakley G. D. Screening for atrial fibrillation in primary care. Heart. 1998 Jan;79(1):50–55. doi: 10.1136/hrt.79.1.50. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The British Journal of General Practice are provided here courtesy of Royal College of General Practitioners

RESOURCES